LadRx Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
LADX Over the counter 2836 www.ladrxcorp.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for LadRx Corporation

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing - Mar 14th, 2025 6:35 am
Life Sciences Investor Forum Agenda Announced for March 13th - Mar 12th, 2025 11:12 am
LadRx Corporation, Inc. to Present at the Virtual Life Science Investor Forum March 13th - Mar 12th, 2025 6:35 am
LadRx Planning NDA Submission under 505(b)(2) for Aldoxorubicin and Other Updates - Dec 11th, 2024 6:30 pm